New York, the state the hardest by the coronavirus, has begun a trial combining hydroxychloroquine with the antibiotic azithromycin following approval by the FDA positive results of a French trial. The White House has plans to roll out a platform which will track patient data including their response to the drugs, enlisting tech giant Oracle to make this happen. Yourway is committed to bettering the health of patients worldwide and can fully support trials, including direct-to-patients trials, even in times of crisis.